SCHEMBL9963558

SCHEMBL9963558

O=C(O)CNc1nc2c(Cl)c3nc(NCC(=O)N4CCCC4)sc3cc2s1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.49
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
FABP4 P15090 1/20 0.38
PRMT3 O60678 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
ALDH1A1 P00352 1/20 0.34
LIPC P11150 1/20 0.34
LIPG Q9Y5X9 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MALT1 Q9UDY8 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963523 0.89 PTGS2 (0.45) PTGS2RAB9ANPC1GAAFABP4
SCHEMBL9963546 0.88 PTGS2 (0.49) PTGS2RAB9AGAAFABP4PRMT3
SCHEMBL9963695 0.88 PTGS2 (0.49) PTGS2RAB9AGAAFABP4PRMT3
SCHEMBL9963544 0.88 PTGS2 (0.48) PTGS2RAB9ANPC1GAAFABP4
SCHEMBL9963545 0.87 PTGS2 (0.51) PTGS2RAB9AGAAFABP4PRMT3
SCHEMBL9963566 0.85 PTGS2 (0.47) PTGS2RAB9AGAAFABP4PRMT3
SCHEMBL9963610 0.83 PTGS2 (0.54) PTGS2RAB9ANPC1FABP4PRMT3
SCHEMBL9963635 0.83 PTGS2 (0.50) PTGS2RAB9ANPC1GAAFABP4
SCHEMBL9963479 0.82 PTGS2 (0.45) PTGS2RAB9ANPC1GAAFABP4
SCHEMBL9966068 0.81 PTGS2 (0.48) PTGS2RAB9AGAAFABP4PRMT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 PTGS2 2872/4885RAB9A 696/4885NPC1 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.